P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
FENC | N/A | N/A | N/A | +12.70% |
FENC Peer | N/A | 26.7 | N/A | -59.23% |
Pharmaceuticals: Major Industry | 23.7 | 16.7 | 0.3 | +48.46% |
Health Technology Sector | 35.5 | 25.6 | 0.5 | -0.41% |
S&P 500 Market | 35.9 | 64.9 | 1.2 | +98.25% |
Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
---|---|---|---|---|
Mean Estimate | -$0.17 | -$0.14 | -$0.11 | -$0.08 |
Previous Mean | -$0.15 | -$0.14 | -$0.11 | -$0.08 |
Standard Deviation | 0.01 | 0.04 | 0.10 | 0.08 |
Low Estimate | -$0.18 | -$0.19 | -$0.18 | -$0.14 |
High Estimate | -$0.15 | -$0.10 | -$0.04 | -$0.02 |